Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoinette S Perry

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 13, 2017
Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancerSílvia Barrabés, Esther Llop, Montserrat Ferrer-Batallé, et al.
The Journal of Urology|August 22, 2012
IGFBP7 promoter methylation and gene expression analysis in prostate cancerLinda Sullivan, Therese M Murphy, Ciara Barrett, et al.
Urologic Oncology|December 24, 2010
Docetaxel maintains its cytotoxic activity under hypoxic conditions in prostate cancer cellsJames C Forde, Antoinette S Perry, Kevin Brennan, et al.
Trends in Cancer|February 27, 2026
Evolving approaches to broaden public and patient involvement in cancer researchAsia Jordan, Claire Hughes, Lea Schäfer, et al.
Clinical Epigenetics|February 13, 2021
5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cellsGordon Greville, Esther Llop, Jane Howard, et al.
Oncotarget|October 1, 2016
Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potentialEamon P Mulvaney, Christine Shilling, Sarah B Eivers, et al.
Epigenetics|February 1, 2020
Evaluating liquid biopsies for methylomic profiling of prostate cancerRomina Silva, Bruce Moran, Niamh M Russell, et al.
Clinical Epigenetics|August 29, 2021
Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancerRomina Silva, Bruce Moran, Anne-Marie Baird, et al.
Histopathology|December 20, 2011
The role of secreted frizzled-related protein 2 expression in prostate cancerGillian O'Hurley, Antoinette S Perry, Anthony O'Grady, et al.
International Journal of Molecular Medicine|September 26, 2012
Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitorSteven G Gray, Anne-Marie Baird, Fardod O'Kelly, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 13, 2017
Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancerSílvia Barrabés, Esther Llop, Montserrat Ferrer-Batallé, et al.
The Journal of Urology|August 22, 2012
IGFBP7 promoter methylation and gene expression analysis in prostate cancerLinda Sullivan, Therese M Murphy, Ciara Barrett, et al.
Urologic Oncology|December 24, 2010
Docetaxel maintains its cytotoxic activity under hypoxic conditions in prostate cancer cellsJames C Forde, Antoinette S Perry, Kevin Brennan, et al.
Trends in Cancer|February 27, 2026
Evolving approaches to broaden public and patient involvement in cancer researchAsia Jordan, Claire Hughes, Lea Schäfer, et al.
Clinical Epigenetics|February 13, 2021
5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cellsGordon Greville, Esther Llop, Jane Howard, et al.
Oncotarget|October 1, 2016
Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potentialEamon P Mulvaney, Christine Shilling, Sarah B Eivers, et al.
Epigenetics|February 1, 2020
Evaluating liquid biopsies for methylomic profiling of prostate cancerRomina Silva, Bruce Moran, Niamh M Russell, et al.
Clinical Epigenetics|August 29, 2021
Longitudinal analysis of individual cfDNA methylome patterns in metastatic prostate cancerRomina Silva, Bruce Moran, Anne-Marie Baird, et al.
Histopathology|December 20, 2011
The role of secreted frizzled-related protein 2 expression in prostate cancerGillian O'Hurley, Antoinette S Perry, Anthony O'Grady, et al.
International Journal of Molecular Medicine|September 26, 2012
Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitorSteven G Gray, Anne-Marie Baird, Fardod O'Kelly, et al.
Pageof 5